BioDuro, an end-to-end life science outsourcing services company, and AstraZeneca have expanded their research collaboration to optimize discovery research for respiratory and inflammation indications.
Subscribe to our email newsletter
BioDuro will provide integrated research services in the areas of discovery chemistry, discovery biology, ADMET, and DMPK services, to help enhance internal drug discovery and shorten development timelines.
Lena Martensson, director of strategic planning and business development at AstraZeneca, said: “After a successful collaboration involving discovery chemistry, ADMET, and DMPK, AstraZeneca has expanded its collaboration with BioDuro to leverage the strengths of its team to help develop new therapeutics.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.